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Council when it was received and that Council members be asked
to comment. Council Agreed.
Council accorded a vote of thanks to Drs. Shapiro and Struthers
for their presentation of the Association's case at the conference.
102. Date and Place of Next Meeting of Council: A the sugges-
tion of Dr. Struthers, Council Agreed that the next meeting would
take place in Pretoria on 13, 14 and 15 October 1955.
103. Chairman's Remarks: The Chairman stated that he was
grateful to members for their co-operation. He hoped that visitors
to the Cape had enjoyed their stay, and on behalf of the Council
he moved that a vote of thanks be accorded to the Red Cross
Society for the facilities which they had afforded, and to Dr.
Purcell and the Civil Service Club for the gesture that had been
made regarding honorary membership of the Club for visiting
members. He also thanked Dr. Purcell for having made the
arrangements with regard to a dinner for members of Federal
Council and the S.A. MedIcal and Dental CounCIl whIch was to
take place that evening.
The votes of thanks were Accorded With Acclamation.
104. Thanks to the Chairman: Dr. Radloff moved a vote of
thanks to the Chairman for the able way in which he had presided
over the meeting. This was Accorded With Acclamation.
The meeting ended at 5.55 p.m.
CONSTITUTION OF THE NATIONAL GENERAL PRACTITIONERS' GROUP
The Steering Committee of the National General Practitioners
Group has forwarded for publication tbe following revised copy
of the revised Constitution of the Group as approved by Federal
Council at its meeting in October 1954:
I.-Name.
The name of the Group shall be The National Group of General
Practitioners of the Medical Association of South Africa'.
H.-Objects.
2. The objects for which the Group is established are:
(a) To promote General Practice.
(b) To define and establish relations amongst General
Practitioners and all Groups of tbe Medical Association
and between General Practitioners and lfospitals, public
and private institutions, government authorities the
medical profession generally and the public. '
(c) To promote the professional and legitimate interests of
General Practitioners.
HL-Membership.
3. Any person who is a registered medical practitioner within
the Umon of South Africa and who is a member of the Medical
Association of South Africa is eligible for membership by virtue
of hiS membership of his branch or section, where such branch
or section exists, and providing:
(a) His professional practice is confined to General Practice.
(b) The nature of his practice is such as to give him a special
mterest in the subject of General Practice.
4. Every member shall remain a member until his member-
ship is terminated either. by his· resignation in writing addressed
to the Honorary Secretary-Treasurer or by decision of the Execu-
tive Committee of the Group. His mem15ership may be suspended
If aft~r one year he has not paid his due subscription, but he may
be remstated on payment of arrear subscriptions due. During
the period of suspension he shall not retain his vote.
. 5. The activities of the Group shall be suspended if, at any
time, Its membership shall be less than 11 (eleven) members.
IV.---Control.
6. The general control and direction of the policy and affairs
of the Group shall be vested in the ational Committee of the
Group and its Executive Committee.
7. The National Committee shall be elected by branches or
sections, each branch having 1 (one) member for the first 50 (fifty)
and thereafter 1 (one) member for every additional 100 (hundred)
or the major portion thereof.
(a) The office bearers and Executive shall be elected by the
National Committee out of their members and shall
consist of a Chairman, two Vice-Chairmen, an Honorary
Secretary Itreasurer, and five members of the Executive.
(b) The Executive or any sub-committee of the National
Committee may co-opt any member or members of the
group for any special purpose, the co-opted member to
be without voting powers.
(c) The National Committee shall meet at least twice a year.
(d) Provision shall be made for proxies with approval of
the branches or section.
8. A list of office bearers, together with a complete list of
members of the Group shall be furnished annually to the Medical
Secretary of the Association within 30 (thirty) days of the election
oJ such office-bearers.
9. The Honorary Secretary ITreasurer of the Group shall
keep records of all meetings of the Group and of the Executive
Committee and shall conduct all correspondence in connection
with the affairs of the Group. He shall receive all monies due to
the Group and shall make all disbursements authorized by the
Executive Committee.
V.-Meetings.
10. The Annual General Meeting shall be held once a year at
or about the time of the Annual General Meeting of the Medical
Association. The quorum shall consist of 20 (twenty) members
inclusive of proxies.
11. General Meetings of the Group may be held from time to
time and shall be called by the Executive Committee on the written
request of 40 (forty) members of the Group. Voting by proxy
shall follow as nearly as is material the form prescribed in the
By-Laws of the Association.
VI.-Action.
12. The Group may take such action as may be deemed
necessary in all matters affecting the legitimate interests of its
members; provided that the Association as a whole be not involved
or pledged to any action and that any action contemplated by the
Group be in conformity with the policy of the· Association for
the time being in force.
13. Should the Group refer a matter affecting the interest of
its members to the Federal Council of the Association for action,
it shall take no further independent action unless requested to
do so by Federal Council.
VH.-Organization.
14. Shall consist of the National Group with branches which
follow closely on the pattern established in the Medical Associa-
tion of South Africa. The branches may divide themselves further
into sections. Such branches may be allowed powers of inde-
pendent action in local matters provided that such action is not
in conflict with the General Policy and rules of the Group and
of the Association in general '
15. The method of election in each branch shall be left to the
discretion of the Executive Committee of the branch or section
that each branch shall elect. Such branch or section shall elect a
Chairman, an Honorary Secretary ITreasurer, and an Executive
Committee consisting of six or more members annually at the
Annual General Meeting of the branch or section, which shall
be held three months prior to the Annual General Meeting of the
Group.
16. Reports of local action taken shall be submitted within
14 (fourteen) days by the Honorary Secretary ITreasurer of the
branch or section to the Honorary Secretary ITreasurer of the
Group.
17. That each branch or section may draw up their own
By-Laws for the conduct of their local affairs including the method
of electIOn of delegates to the ~ational Committee. Nothing in
these By-Laws shall be m conflld with the Constitution of the
NatIOnal Group.
S.A. TYDSKRIF VIR GENEESKUNDE14 Mei 1955
VIll.-Subscriptions.
18. An Annual Subscription of £1 Os. Od. shall be payable
by members of the Group to provide funds for the carrying out
of the work of the-Group.
19. It shall be competent for the amount of this subscrip-
tion to be altered by majority vote at the Annual General Meeting
of the Group.
20. The subscriptions shall be collected by the Honorary
Secretary /Treasurer of the ational Group. All accounts shall
be subject to audit and branches or sections may claim legitimate
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expenses in the connection with the running of their branch,
these not to exceed 50% of the paid up subscriptions of their
members for that year.
IX.-Annual Report.
The Honorary Secretary /Treasurer shall submit an Annual
Report and a Financial Statement at the Annual General Meeting
of the Group. A copy of each shall thereafter be sent to the
Medical Secretary of. the Association within 30 (thirty) days of
the meeting of the Federal Council of the Association.
POSTGRADUATE MEDICAL EDUCATION
VACCINATION AGAINST PARALYTIC POLIOMYELITIS: PERFORMANCE AND PROSPECTS
ABSTRACf OF A PAPER BY DR. JO AS E. SALK OF THE VIRUS RESEARCH LABORATORY, SCHOOL OF
MEDICThTE, UNIVERSITY OF PITTSBURG
The American Medical Association announces that during a
recent period of 2t years its Council on Medical Education and
Hospitals has been engaged in a comprehensive survey of post-
graduate medical education in the United States. The use of the
term postgraduate education has come to be distinguished from
graduate medical education as follows:
Graduate education includes relatively long periods of training
such as intemships, residencies, fellowships and formal academic
work, which lead either to specialty status or an advanced academic
degree.
Postgraduate education refers to somewhat broader periods of
study of perhaps a few days to a few months and which are de-
signed to refresh a practitioner in his own field of practice or extend
his knowledge of one particular element of it.
The survey of postgraduate facilities has included field visita-
tions to most of the 300 or more institutions and organizations
in the USA offering postgraduate courses.
A preliminary report of the findings of the survey was pre-
The paper of which the following is an abstract was presented
by Dr. Salk at the conference held at the University of Michigan
on 12 April 1955./ It was accompanied by many charts illustrating
the results of experiments. The paper had been prepared without
prior knowledge of Dr. Frances' report on the 1954 Poliomyelitis
Vaccine Field Test.
Dr. Salk- said that with killed-virus preparations the destruction
of infectivity and the reaction of immunological response were
governed by definable laws. The destruction of infectivity with
formaldehyde proceeds as does' a first-order chemical process,
and the time required can be predicted rather precisely. ]n the
production of the vaccine the antibody-producing power is not
measurably reduced unless over-treatment is extended for a period
more than 5 times that required to reduce infectivity to a point
at which it is no longer measurable. This is an ample margin of
safety. Moreover the vaccine is so stable that no special pre-
cautions are required for its maintenance.
The amount of killed-virus polio vaccine required to produce im-
mune response in man is far less than might have been anticipated
from comparison with most other microbial antigens; and it is much
easier to produce immune response in man than in the monkey,
and in the monkey than in the mouse. Moreover the antibody
persists much longer in man than in monkey or mouse.
The optimum immunological response to two injections of the
killed-vaccine is obtained in the monkey if they are separated by
an interval of 4 weeks. In the mouse the optimum interval is much
shorter; in man it is much longer (months rather than weeks).
These facts were known before the 1954 Field Test, but there
was not time to put them in practice, and the test was therefore
of the question whether primary vaccination alone could prevent
paralytic poliomyelitis rather than of the effectiveness of full
immunization, which could have been achieved only if the course
sented at the 50th Annual Congress on Medical Education and
Licensure a year ago. Since then, the material collected during
the study has been worked up into a final report. This will be
published during 1955 as a series of special articles in forthcoming
issues of the Journal ofthe American Medical Association as follows:
26 February-The Scope and Extent of Postgraduate Medical
Education in the United States. 12 March-The Physician as a
Lifelong Student. 26 March-The Objectives and Content of
Postgraduate Medical Education. 9 April-Educational Methods
in Postgraduate Teaching. 23 April-Time and Place Arrange-
ments of Postgraduate Courses for Practising Physicians. 7 May-
Sponsorship and Administration of Postgraduate Medical Educa-
tion. 21 May-Financing Postgraduate Medical Education.
4 June-The Future of Postgraduate Medical Education.
After the Journal publication of the last of these articles, the
entire series will be reprinted in monograph form, to which will
be added a section on the 'History of Postgraduate Medical
Education' and a number of appendices containing additional
detailed material derived from the survey.
of innoculations had been extended over a number of months at
least.
It has been shown that if merthiolate is added to the vaccine
to inhib)t bacterial or mould contamination its antigenic property
steadily declines over a period of months. The effect of merthio-
late is more rapid at a higher temperature, effecting almost com-
plete destruction of antigenicity within a few days at 37° C; but
under certain circumstances rapid deterioration has been observed
even at refrigerator temperatures. The effect is quickest in the
type-I component, next for type Il, and last for type Ill. Certain
of the vaccine used in the Field Test was merthiolated, and tests
of the effects on children of'a number of lots of vaccine used in
the Field Test have shown substantial reduction of immunizing
power in certain lots. This is largely attributed to the merthiolate,
but also, perhaps, to variation in the starting material.
It has been shown (1955) that if versene is added to the polio
vaccine in addition to I : 10,000 merthiolate the destructive effect
of the merthiolate is prevented while its antiseptic or preservative
qualities are retained. The solution of the merthiolate problem
by the addition of versene is the result of the efforts of the Research
Staff at Eli Lilly and Company. Other laboratories similarly
engaged in vaccine production are solving the preservative problem
in a number of ways, either by not using it at all, as is the case
at the Connaught Research Laboratories, in Canada, and in
certain European laboratories, or by the use of other chemicals
that can be shown to exercise the necessary anti-microbial effect
without impairing antigenic activity.'
As the result of experience polio vaccine is being prepared in
1955 of greater potency than the vaccines used in 1954.
Dr. Salk again emphasized that the 2nd ('booster') dose of
polio vaccine should not be given until at least 7 months after
the 1st dose of vaccine, if the maximum effect is to be obtained.
